A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup developing a drug combo that aims to slow progression of ALS and other neurodegenerative diseases.
Study suggests that the course of the fatal neurodegenerative disease can be delayed and even reversed in its early stages.
Neuromagen Pharma secures funding to test a new class of small molecules to treat amyotrophic lateral sclerosis and other neurodegenerative diseases.
The findings suggest that in the future, various means of altering the microbiome may be harnessed for developing new therapeutic options for ALS.
Precision medicine breakthrough from Israel helps find markers for personalized care and improving drug development for neurodegenerative diseases.
A mechanism involving specific microRNA and muscle molecules is found to play a role in the development of amyotrophic lateral sclerosis.
Amazing new technologies for beating conditions including breast cancer, ALS and obesity are under development in Israel’s capital city.
BrainStorm Cell Therapeutics’ NurOwn platform enhances a patient’s own adult stem cells to halt progression of incurable neurodegenerative diseases.
New drug candidate may prove effective in boosting the self-cleansing mechanism of the human brain, thereby improving the lives of millions of people.
Google teams up with Sesame Enable and Beit Issie Shapiro to change lives in Israel.
Israeli entrepreneurs launch crowdfunding campaign to make affordable smart glasses enabling ALS, stroke sufferers to communicate
Israel’s Kadimastem is testing its technology for differentiating pluripotent stem cells into a range of functional human cells.
From the first blood test for cancer to inventions that can save your life, and a reinvented wheel, we look back at some of our most exciting stories of the year.
Israeli startup developing voice-translation technology for people with ALS, autism, and Parkinson’s disease.
Seatylock, Bleep, Look, Offer Green: four new Israeli crowdfunding campaigns you should know about.
